Clinical trial
Study With GW274150 In Patients With Mild Asthma
NCT00273013 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00273013 |
|---|---|
| Title | Study With GW274150 In Patients With Mild Asthma |
| Official title | Single Centre Allergen Challenge Study of GW274150 in Mild Asthmatic Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW274150, Singulair, Placebo |
| Enrollment | 28 |
| Start date | Nov 15, 2004 |
| Primary completion | Oct 28, 2005 |
| Completion | Oct 28, 2005 |
| First posted | Jan 9, 2006 |
| Last update posted | Oct 18, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: